SESN
Price:
$0.6288
Market Cap:
$127.96M
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment of bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer; to treat non-muscle invasive carcinoma in situ of the bladder in patients previously treated with BCG; and for the treatment of squamous cell carcinoma of the head and neck, as well as VB6-845d, a product candidate for use in the treatment of various types of an anti-e...[Read more]
Industry
Biotechnology
IPO Date
2014-02-06
Stock Exchange
NASDAQ
Ticker
SESN
According to Sesen Bio, Inc.’s latest financial reports and current stock price. The company's current ROE is -90.96%. This represents a change of 218.21% compared to the average of -28.59% of the last 4 quarters.
The mean historical ROE of Sesen Bio, Inc. over the last ten years is -37.10%. The current -90.96% ROE has changed 145.22% with respect to the historical average. Over the past ten years (40 quarters), SESN's ROE was at its highest in in the June 2020 quarter at 1.00%. The ROE was at its lowest in in the March 2021 quarter at -598.83%.
Average
-37.10%
Median
-45.31%
Minimum
-768.33%
Maximum
670.86%
Discovering the peaks and valleys of Sesen Bio, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.32%
Maximum Annual ROE = 670.86%
Minimum Annual Increase = -3392.31%
Minimum Annual ROE = -768.33%
Year | ROE | Change |
---|---|---|
2022 | -12.57% | 6.32% |
2021 | -0.20% | -100.08% |
2020 | 242.73% | -63.82% |
2019 | 670.86% | -959.62% |
2018 | -78.04% | -51.52% |
2017 | -160.97% | -3392.31% |
2016 | 4.89% | -102.77% |
2015 | -176.58% | 90.39% |
2014 | -92.75% | -87.93% |
2013 | -768.33% | 124.32% |
The current ROE of Sesen Bio, Inc. (SESN) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
76.66%
5-year avg
164.56%
10-year avg
-37.10%
Sesen Bio, Inc.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sesen Bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sesen Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Sesen Bio, Inc.'s ROE?
How is the ROE calculated for Sesen Bio, Inc. (SESN)?
What is the highest ROE for Sesen Bio, Inc. (SESN)?
What is the 3-year average ROE for Sesen Bio, Inc. (SESN)?
What is the 5-year average ROE for Sesen Bio, Inc. (SESN)?
How does the current ROE for Sesen Bio, Inc. (SESN) compare to its historical average?